The Waters ACQUITY Arc System Receives 2016 Frost & Sullivan New Product Innovation Award
Bridging the gap between HPLC and UPLC performance, the ACQUITY Arc System is a favorite of QC laboratories that test small and large molecule pharmaceuticals.
Frost & Sullivan has a global team of analysts and consultants continuously researching a wide range of markets across multiple sectors and geographies. As part of this ongoing research, their research analysts identify companies that have successfully introduced new and innovative products into their markets, with emphasis on product quality and customer value.
We first introduced the ACQUITY Arc System in June of 2015 in Beijing, China. The goal was to provide analytical scientists with a tool to ease the challenges of method transfer between systems, without the need to fully revalidate those methods – a particular problem when older instrumentation becomes out of date.
Janani Balasundar, Research Analyst at Frost & Sullivan, noted, “In the regulated environment in which pharmaceutical companies operate, they are by nature conservative when it comes to adopting new technologies, and they prefer “tried and true” methods especially when it comes to later stages of the drug development and commercialization process.”
Janani continued, “With the ACQUITY Arc System, Waters has given pharmaceutical companies the capability of introducing a single LC platform for their workflows for improving analytical method performance and thereby productivity while maintaining CGMP compliance.”
— Waters Corporation (@WatersCorp) June 15, 2015
With the ACQUITY Arc System and its enabling Arc Multi-flow path™ technology, analytical scientists can experience true plug-and-play method compatibility for separation needs. Significant productivity gains can be realized by deploying a single chromatography platform that allows the efficient transfer, adjustment, or improvement of methods from any LC platform without compromise. This technology provides chromatographers with critical tools to focus and maintain CGMP compliance in requlated environments.
“On behalf of the ACQUITY Arc product team, we are thankful to Frost & Sullivan for this honor,” said Mike Yelle, Vice President – Separations, Waters Corporation. “The award recognizes the commercial success of the ACQUITY Arc System and the positive impact it is having on laboratories, in Asia and elsewhere, that are supporting business-critical analytical methods.”
The Frost & Sullivan Award is actually the second time that the ACQUITY Arc has received a top award. At the annual Pittcon Conference in the spring of 2016, Select Science announced the system won the Scientists’ Choice Award for Best New Separations Product of 2015.
— Waters Corporation (@WatersCorp) March 8, 2016
Thanks to our customers for recognizing the impact that the ACQUITY Arc System has in analytical laboratories!
Please find below a list of the latest diverse ACQUITY Arc applications.
Improving HPLC and UHPLC separations methods:
- Improve HPLC Methods by Increasing Sample Throughput Using the ACQUITY Arc System
- Dwell Volume and Extra-Column Volume: What Are They and How Do They Impact Method Transfer
- Simplifying Methods Transfer: Novel Tools for Replicating your Established Methods on an ACQUITY Arc System
For small molecules:
- Soft Drink Analysis on an ACQUITY Arc System
- Analysis of Disperse Dyes Using the ACQUITY Arc System with PDA and Mass Detection, and Empower Software
- UHPLC Analysis of a Pesticide Formulation Using the ACQUITY Arc System with PDA, Mass Detection, and Empower 3 Software
- Profiling Mono and Disaccharides in Milk and Infant Formula Using the ACQUITY Arc System and ACQUITY QDa Detector
- Profiling and Quantification of Mono and Disaccharides and Selected Alditols in Juice, Beer, Wine, and Whiskey
- Transfer of the HPLC Method for Analysis of Metoclopramide HCl and Related Substances from an Agilent 1100 Series LC System to an ACQUITY Arc System
- Transfer of the HPLC Method for Analysis of Metoclopramide HCl and Related Substances from an Agilent 1260 Infinity LC System to an ACQUITY Arc System
- Improved Performance and Cycle Time for the Analysis of Lipid Soluble Antioxidants Using CORTECS T3 Columns on the ACQUITY Arc System
For large molecules:
- Method Transfer and Reliability of the ACQUITY Arc for Peptide Mapping
- Transferring Methods for Monoclonal Antibody Analysis from an Agilent 1260 Infinity Quaternary LC System to an ACQUITY Arc System
- IEX Method Transfer: Replicating a Method for Monoclonal Antibody Analysis on an ACQUITY Arc System
- Transfer of an SEC Method for Monoclonal Antibody Analysis from HPLC to UHPLC Using the ACQUITY Arc System
View the full press release here: https://www.businesswire.com/news/home/20161004005211/en/